Core Viewpoint - Labcorp reported quarterly earnings of $3.45 per share, exceeding the Zacks Consensus Estimate of $3.40 per share, and showing an increase from $3.30 per share a year ago, indicating a positive earnings surprise of 1.47% [1] Financial Performance - Labcorp's revenues for the quarter ended December 2024 were $3.33 billion, surpassing the Zacks Consensus Estimate by 0.44%, and up from $3.03 billion year-over-year [2] - The company has consistently outperformed consensus EPS and revenue estimates over the last four quarters [2] Stock Performance - Labcorp shares have increased approximately 9% since the beginning of the year, compared to a 3.1% gain in the S&P 500 [3] - The stock currently holds a Zacks Rank 2 (Buy), indicating expectations of outperforming the market in the near future [6] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $3.90 on revenues of $3.42 billion, and for the current fiscal year, it is $15.97 on revenues of $13.84 billion [7] - The trend of estimate revisions for Labcorp has been favorable leading up to the earnings release [6] Industry Context - The Medical - Dental Supplies industry, to which Labcorp belongs, is currently ranked in the bottom 40% of over 250 Zacks industries, which may impact stock performance [8]

FOR IMMEDIATE RELEASE Media Investors Media@Labcorp.com Investor@labcorp.com Labcorp Announces 2024 Fourth Quarter and Full Year Results Company Provides 2025 Guidance BURLINGTON, N.C., February 6, 2025 – Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced results for the fourth quarter ended December 31, 2024, and provided 2025 guidance. "In 2024, Labcorp delivered exceptional results driven by both organic and inorganic growth," said Adam ...

Company Provides 2025 Guidance Results from Continuing Operations versus last year: Revenue: Q4 of $3.33 billion vs $3.03 billion; Full year of $13.01 billion vs $12.16 billion Diluted EPS: Q4 of $1.70 vs $(1.95); Full year of $8.84 vs $4.33 Adjusted EPS: Q4 of $3.45 vs $3.30; Full year of $14.57 vs $13.56 Free Cash Flow: Q4 of $665.1 million vs $412.4 million; Full year of $1.10 billion vs $748.7 million Announced 10 transactions and launched new innovative tests meeting significant unmet medical needs ...

The upcoming report from Labcorp (LH) is expected to reveal quarterly earnings of $3.40 per share, indicating an increase of 3% compared to the year-ago period. Analysts forecast revenues of $3.31 billion, representing an increase of 9.3% year over year.The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.Ahead of a company's earnings disclosure, it is cruc ...

Labcorp Holdings Inc. (LH) , or Labcorp, is slated to report its fourth-quarter 2024 results on Feb. 6 before the opening bell.Find the latest EPS estimates and surprises on Zacks Earnings Calendar.The renowned laboratory service provider reported adjusted earnings of $3.50 in the last reported quarter, topping the Zacks Consensus Estimate by 0.56%. Labcorp surpassed estimates in each of the trailing four quarters, the average surprise being 2.87%.LH’s Q4 EstimatesThe Zacks Consensus Estimate for Labcorp’s ...

Labcorp (LH) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2024. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on February 6. On ...

BURLINGTON, N.C., Jan. 10, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that the company will participate in a fireside chat at the 43rd Annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 14, at 3:45 p.m. (PT). A live audio webcast of the fireside chat will be available via the Company Investor Relations website at ir.Labcorp.com and archived for replay.  About LabcorpLabcorp (NYSE: LH) is a global leader of innovative a ...

If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider Labcorp (LH) . This company, which is in the Zacks Medical - Dental Supplies industry, shows potential for another earnings beat.This medical laboratory operator has seen a nice streak of beating earnings estimates, especially when looking at the previous two reports. The average surprise for the last two quarters was 2.40%.Fo ...

BURLINGTON, N.C., Jan. 8, 2025 /PRNewswire/ -- Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that its Board of Directors has declared a cash dividend of $0.72 per share of common stock. The dividend will be payable on March 12, 2025, to stockholders of record as of the close of business on February 27, 2025.About LabcorpLabcorp (NYSE: LH) is a global leader of innovative and comprehensive laboratory services that helps doctors, hospita ...

BURLINGTON, N.C., Jan. 8, 2025 /PRNewswire/ -- Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the fourth quarter of 2024 before the market opens on Thursday, February 6, 2025. The company will host a conference call and webcast beginning at 9 a.m. ET that day to discuss the results. The earnings press release and accompanying financial information will be posted on the Labcorp Investor Relations website.The call w ...